<SEC-DOCUMENT>0001493152-23-000848.txt : 20240417
<SEC-HEADER>0001493152-23-000848.hdr.sgml : 20240417
<ACCEPTANCE-DATETIME>20230106183103
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001493152-23-000848
CONFORMED SUBMISSION TYPE:	DRSLTR
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LOBO EV TECHNOLOGIES LTD
		CENTRAL INDEX KEY:			0001932072
		STANDARD INDUSTRIAL CLASSIFICATION:	MOTORCYCLES, BICYCLES & PARTS [3751]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		DRSLTR

	BUSINESS ADDRESS:	
		STREET 1:		XINWU DISTRICT
		STREET 2:		WUXI
		CITY:			JIANGSU
		STATE:			F4
		ZIP:			214111
		BUSINESS PHONE:		86 510 88584252

	MAIL ADDRESS:	
		STREET 1:		XINWU DISTRICT
		STREET 2:		WUXI
		CITY:			JIANGSU
		STATE:			F4
		ZIP:			214111
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRSLTR
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify"><IMG SRC="formdrsltr_001.jpg" ALT=""></TD>
    <TD STYLE="width: 38%"><FONT STYLE="font-size: 10pt">2206-19 Jardine House 1<BR>
Connaught Road Central Hong<BR>
Kong SAR</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-size: 10pt"><B>Direct<BR>
Main<BR>
Fax</B></FONT></TD>
    <TD STYLE="width: 15%"><FONT STYLE="font-size: 10pt">+852-3923-1111<BR>
+852-3923-1111<BR>
+852-3923-1100</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">January 06, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">United States Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Office of Trade &amp; Services</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Attn: Bradley Ecker and Geoffrey Kruczek</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 35pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Re:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>LOBO EV TECHNOLOGIES LTD</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Amendment No. 2 to Draft Registration Statement on Form F-1</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Submitted December 9, 2022</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>CIK No. 0001932072</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dear Mr. Ecker and Mr. Kruczek:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On behalf of our client, LOBO EV Technologies Ltd.
(the &ldquo;<B>Company</B>&rdquo;), we respond to the comments of the staff of the Division of Corporation Finance of the Commission (the
&ldquo;<B>Staff</B>&rdquo;) with respect to the above-referenced Amendment No .2 to Draft Registration Statement on Form F-1 submitted
on December 9, 2022, (the &ldquo;<B>Registration Statement</B>&rdquo;) contained in the Staff&rsquo;s letter dated December 21, 2022 (the
&ldquo;<B>Comment Letter</B>&rdquo;).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has filed via EDGAR Amendment No. 3 to
the Draft Registration Statement (the &ldquo;<B>Amendment</B>&rdquo;), which reflects the Company&rsquo;s responses to the comments received
by the Staff and certain updated information. For ease of reference, each comment contained in the Comment Letter is printed below and
is followed by the Company&rsquo;s response. All page references in the responses set forth below refer to the page numbers in the Amendment.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Confidential Draft Registration Statement on Form F-1 submitted
December 9, 2022</U></P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Our principal shareholders have substantial influence over our
company. Their interests may not be aligned with the interests..., page 50</U></P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in">1.</TD><TD STYLE="text-align: justify">We note your response to our prior comment 3 and reissue. Your revised disclosure, that your principal shareholders &ldquo;will beneficially
own approximately [&nbsp;&nbsp;]% of [y]our outstanding Ordinary Shares representing more than 50% of the voting power of the Company,&rdquo; continues
to imply that there will be multiple classes of stock outstanding after this offering, each with different voting rights. If that is not
true, please revise to eliminate that implication. If it is true, revise throughout to discuss the terms of and risks related to the different
classes of stock.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Response: <FONT STYLE="font-weight: normal">The Company has amended
page 50 of the Amendment in response to the Staff&rsquo;s comment.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Management&rsquo;s Discussion and Analysis
of Financial Condition and Results of Operations Components of Operations</U></P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0"><U>Revenues, page 65</U></P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"></P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in">2.</TD><TD STYLE="text-align: justify">We note your discussion on pages 2-3 (&ldquo;Brief introduction to our products&rdquo;) where you identify the various products you
offer along with the amount of revenues generated from sales of such products. Please revise your MD&amp;A to provide a more detailed
and granular discussion that would provide greater transparency into the material components and potential variability of your revenues.
For example, your disclosures should:</TD></TR></TABLE>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify">identify and quantify each individually significant component of revenues;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify">quantify the change in each respective component during each period; and</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify">discuss the reasons for the increases or decreases in the specific dollar amounts for each of the components identified. Supplement
your discussion with additional information that would be meaningful to an investor (e.g., in comparative tabular format, quantify the
number of units sold for the respective reporting periods).</TD></TR></TABLE>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Response: <FONT STYLE="font-weight: normal">The Company has amended
pages 65 and 70 of the Amendment in response to the Staff&rsquo;s comment.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><U>Business, page 97</U></P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in">3.</TD><TD STYLE="text-align: justify">We note your response to our prior comment 5. Please disclose whether and to what extent you rely on third-party manufacturing for
your products. In this regard, we note your disclosure on page 27 that you &ldquo;purchase certain key components and raw material, such
as batteries, motors, tires, battery chargers and controllers from external suppliers for use in [y]our operations and production of products.&rdquo;
Also, as previously requested, disclose the extent of utilization of your facilities.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Response: <FONT STYLE="font-weight: normal">The Company has amended
page 102 in response to the Staff&rsquo;s comments.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Strengthen cost control, page 101</U></P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in">4.</TD><TD STYLE="text-align: justify">We note your response to our prior comment 7. Please revise to expand how you intend to implement cost control with specific, concrete
examples, including how the examples you provide actually lowered procurement costs.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Response: <FONT STYLE="font-weight: normal">The Company has amended
page 101 in response to the Staff&rsquo;s comments.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Related Party Transactions, page 123</U></P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in">5.</TD><TD STYLE="text-align: justify">We note your response to prior comment 9. Please update the disclosure to be as of the most recent practicable date. Currently, your
disclosure is as of June 30, 2022, which more than five months prior to the date of this submission.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Response: <FONT STYLE="font-weight: normal">The Company has amended
page 123 of the Amendment in response to the Staff&rsquo;s comment.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><U>General</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in">6.</TD><TD STYLE="text-align: justify">We note your interim financial statements provided in response to prior comment 11. Please also update all relevant sections throughout
the F-1 where financial information is presented to include this interim financial data. In this regard, we note your summary information
on page 13, capitalization and dilution should be updated.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Response: <FONT STYLE="font-weight: normal">The
Company has amended page 13 and other relevant sections of the Amendment in response to the Staff&rsquo;s comment</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in">7.</TD><TD STYLE="text-align: justify">The first full risk factor on page 23 indicates that your operations have not been materially and negatively impacted by COVID-related
matters during 2022. Please reconcile with the disclosures on pages 64-65. Also update the disclosure in the last two paragraphs on page
62.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Response: <FONT STYLE="font-weight: normal">The Company has amended
pages 23 and 62 in response to the Staff&rsquo;s comment.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Please do not hesitate to contact Lawrence Venick at
(310) 728-5129 of Loeb &amp; Loeb LLP with any questions or comments regarding this letter.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-size: 10pt">Sincerely,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Loeb &amp; Loeb LLP</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Loeb &amp; Loeb LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">cc: Huajian Xu</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>formdrsltr_001.jpg
<TEXT>
begin 644 formdrsltr_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Q '$# 2(  A$! Q$!_\0
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M?6M[PE:W.H?#K68H-1CL96O8F,\LI0?F/6AU)*/,)0BY6.;?P'XJ12S:)<X
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H"BBB@ [T444 %%%%/H 4444 %%%%( /6CM110,****;$%%%%(#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
